Zimmer Biomet, InMode And The World's Largest Investment Firm: CNBC's 'Final Trades'
Portfolio Pulse from Lisa Levin
CNBC's 'Halftime Report Final Trades' featured Zimmer Biomet, InMode, and BlackRock. Zimmer Biomet reported better-than-expected Q1 adjusted EPS, while BlackRock plans to raise up to $7 billion for its fourth Global Renewable Power Fund. InMode reported a Q1 earnings beat but lagged in annual outlook.
June 15, 2023 | 12:26 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
InMode reported a Q1 earnings beat but lagged in annual outlook.
InMode's mixed Q1 earnings report, with a beat on earnings but a lagging annual outlook, may result in a neutral short-term impact on its stock price, as investors weigh the positive and negative aspects of the company's performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
BlackRock plans to raise up to $7 billion for its fourth Global Renewable Power Fund.
BlackRock's plan to raise a significant amount for its renewable power fund may have a positive short-term impact on its stock price, as it demonstrates the company's commitment to sustainable investments and growth.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Zimmer Biomet reported better-than-expected Q1 adjusted EPS of $1.89, compared to the consensus estimate of $1.64.
Zimmer Biomet's better-than-expected Q1 earnings may lead to a positive short-term impact on its stock price, as investors may view the company's financial performance as a sign of strength.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100